China SXT PharmaceuticalsSXTC 
$0.63-8.84%24h
-8.84%24h
Global rank
Market cap$355.72K
Change 7d-46.24%
YTD Performance-75.90%
SP500 benchmarkUnderperform
P/E0
P/S0.18
Revenue$1.97M
Earnings-$5.93M
Dividend yield-
Main Sector
Healthcare
Category
China SXT Pharmaceuticals Revenue data
According to China SXT Pharmaceuticals latest financial reports the company had revenue of $1.97M in 2023-03-31, a -24.23% decrease from 2022. China SXT Pharmaceuticals highest revenue was $5.16M in 2020.
Revenue history for China SXT Pharmaceuticals from 2020 to 2024
-
Value:-
China SXT Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.97M | -24.23% |
| 2022 | $2.60M | -45.53% |
| 2021 | $4.78M | -7.45% |
| 2020 | $5.16M | - |
View the top revenue stocks 
